Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Inventory (2020 - 2025)

RxSight's Inventory history spans 6 years, with the latest figure at $33.5 million for Q4 2025.

  • For Q4 2025, Inventory rose 48.22% year-over-year to $33.5 million; the TTM value through Dec 2025 reached $33.5 million, up 48.22%, while the annual FY2025 figure was $33.5 million, 48.22% up from the prior year.
  • Inventory reached $33.5 million in Q4 2025 per RXST's latest filing, up from $30.4 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $33.5 million in Q4 2025 to a low of $8.0 million in Q4 2021.
  • Average Inventory over 5 years is $18.3 million, with a median of $18.3 million recorded in 2023.
  • Peak YoY movement for Inventory: decreased 6.65% in 2021, then skyrocketed 112.8% in 2023.
  • A 5-year view of Inventory shows it stood at $8.0 million in 2021, then soared by 84.7% to $14.8 million in 2022, then rose by 20.78% to $17.9 million in 2023, then increased by 26.26% to $22.6 million in 2024, then surged by 48.22% to $33.5 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Inventory are $33.5 million (Q4 2025), $30.4 million (Q3 2025), and $25.1 million (Q2 2025).